Joint
Joint, licence 80096649: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- Origin Labs, LLC.
- NPN or DIN-HM
- 80096649
- Status
- Active licence
- Licence date
- 15 January 2020
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Chlorhydrate de 2-amino-2-désoxy-bêta-D-glucopyranose Source : Exosquelette de crevette | 250.0 mg | Not calculated |
| Chlorhydrate de 2-amino-2-désoxy-bêta-D-glucopyranose Source : Exosquelette de crabe | 250.0 mg | Not calculated |
| Cucumaria frondosa Source : En entier | 50.0 mg | Not calculated |
| Méthylsulfonylméthane Source : Sulfone de diméthyl | 166.67 mg | Not calculated |
| Boswellia serrata Source : Stem bark oleogum resin Extract : Matériel brut sec Extraction ratio : 1.667:1 Dry plant equivalent : 77.23 mg Potency : 65.0 % Boswellic acids | 46.33 mg | Not calculated |
Non-medicinal ingredients
Dioxyde de silicium, Gélatine, farine de riz
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19.0 Année(s) | 3.0 Capsule | 2.0 Tous les jours |
Uses authorised in Canada
A factor in maintaining healthy cartilage. A factor in maintaining joint health. Helps to maintain healthy cartilage. Helps to maintain joint health.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Effets indésirables connus
Stop use if hypersensitivity/allergy occurs. Stop use if diarrhoea, abdominal pain, heartburn, nausea or vomiting occur. Some people may experience mild gastrointestinal bloating, constipation or indigestion.
Source
Official Health Canada record, licence 80096649
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.